Open | - |
Close | - |
Volume / Avg. | 0 / 378.096K |
Day Range | - - - |
52 Wk Range | 12.540 - 28.910 |
Market Cap | $913.673M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 9.05% |
Days to Cover | 9.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bicycle Therapeutics (NASDAQ: BCYC) through any online brokerage.
Other companies in Bicycle Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), ARS Pharmaceuticals (NASDAQ:SPRY), Zentalis Pharma (NASDAQ:ZNTL) and Centessa Pharmaceuticals (NASDAQ:CNTA).
The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by Canaccord Genuity on Wednesday, February 21, 2024. The analyst firm set a price target for 60.00 expecting BCYC to rise to within 12 months (a possible 148.76% upside). 25 analyst firms have reported ratings in the last year.
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $24.12 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Bicycle Therapeutics.
Bicycle Therapeutics’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Bicycle Therapeutics.
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.